Profile data is unavailable for this security.
About the company
Shenzhen Lifotronic Technology Co Ltd is a China-based company primarily engaged in the research, development, manufacturing, and marketing of medical devices. The Company operates through four businesses. The in-vitro diagnostics business primarily offers products such as chemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, and specific protein analyzers. The clinical medical business primarily offers products such as photon therapy devices, air wave pressure therapy systems, and high-frequency vibration sputum clearance systems. The dermatological aesthetics business primarily offers products such as semiconductor laser therapy devices, extracorporeal shock wave therapy devices, and aesthetic medical consumables. The consumer health business primarily offers products such as facial mask-style photon beauty devices, smart hair care caps, and infrared therapy devices. The Company distributes its products within the domestic market and to overseas markets.
- Revenue in CNY (TTM)1.05bn
- Net income in CNY251.02m
- Incorporated2008
- Employees1.67k
- LocationShenzhen Lifotronic Technology Co Ltd4F, Building 15No. 1008, Xili Songbai RoadNanshan DistrictShenzhen 518000ChinaCHN
- Phone+86 75 529060052
- Fax+86 75 529060036
- Websitehttps://www.lifotronic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Ags Medtech Co Ltd | 668.70m | 272.95m | 4.98bn | 744.00 | 18.19 | 2.00 | -- | 7.44 | 3.37 | 3.37 | 8.25 | 30.67 | 0.2673 | 3.31 | 11.94 | 898,793.60 | 10.91 | -- | 11.39 | -- | 69.67 | -- | 40.82 | -- | 18.27 | -- | 0.001 | -- | 25.14 | -- | 35.06 | -- | -- | -- |
| Zhejiang Orient Gene Biotech Co Ltd | 842.11m | -479.50m | 5.01bn | 2.28k | -- | 0.787 | -- | 5.94 | -2.48 | -2.48 | 4.37 | 31.55 | 0.107 | 1.44 | 3.39 | 369,997.60 | -6.68 | 21.19 | -7.77 | 26.74 | 34.88 | 58.52 | -62.43 | 32.42 | 3.86 | -- | 0.0462 | 24.78 | 0.946 | 17.65 | -33.06 | -- | 138.80 | -- |
| Assure Tech (Hangzhou) Co Ltd | 462.72m | 120.87m | 5.04bn | 741.00 | 41.72 | 0.9768 | -- | 10.90 | 0.9511 | 0.9511 | 3.64 | 40.62 | 0.0809 | 2.22 | 2.17 | 624,449.30 | 2.11 | 23.69 | 2.30 | 28.01 | 30.32 | 64.61 | 26.11 | 47.65 | 11.28 | -- | 0.0012 | 18.78 | 7.42 | 20.85 | 35.85 | 28.69 | 63.16 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 433.83m | 125.95m | 5.42bn | 639.00 | 43.03 | 3.27 | -- | 12.49 | 1.32 | 1.32 | 4.53 | 17.31 | 0.2411 | 4.00 | 14.42 | 678,922.30 | 7.00 | 8.39 | 7.63 | 9.20 | 61.24 | 71.62 | 29.03 | 32.76 | 6.54 | -- | 0.0182 | 59.13 | -13.45 | 4.64 | -25.16 | 0.4474 | 39.73 | -- |
| Hangzhou Biotest Biotech Co Ltd | 478.69m | 102.57m | 5.44bn | 603.00 | 52.28 | 2.33 | -- | 11.36 | 0.6964 | 0.6964 | 3.06 | 15.66 | 0.1913 | 3.20 | 5.70 | 793,854.10 | 4.02 | 23.63 | 4.25 | 26.20 | 50.57 | 56.59 | 21.00 | 41.47 | 13.08 | -- | 0.00008 | 34.42 | 26.53 | 21.78 | 59.01 | 43.12 | 44.08 | -- |
| SWS Hemodialysis Care Co Ltd | 733.59m | 113.43m | 5.52bn | 1.10k | 48.84 | 3.13 | -- | 7.53 | 0.3538 | 0.3538 | 2.29 | 5.52 | 0.3577 | 2.80 | 6.23 | 665,688.20 | 5.23 | 5.68 | 5.83 | 6.54 | 45.71 | 45.79 | 14.61 | 16.06 | 5.25 | -- | 0.0014 | 28.46 | -17.80 | 31.86 | -63.55 | -- | 24.70 | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 671.62m | -72.38m | 5.76bn | 1.22k | -- | 4.62 | -- | 8.57 | -0.5475 | -0.5475 | 5.10 | 9.25 | 0.3834 | 1.02 | 2.29 | 552,775.60 | -4.14 | 3.01 | -5.15 | 3.34 | 61.79 | 68.86 | -10.80 | 7.52 | 1.57 | -- | 0.2086 | 43.30 | 10.54 | 20.28 | -63.68 | -16.86 | 23.29 | -- |
| Qingdao NovelBeam Technology Co Ltd | 571.80m | 174.33m | 5.85bn | 841.00 | 33.62 | 4.44 | -- | 10.23 | 1.45 | 1.45 | 4.76 | 10.99 | 0.3817 | 0.9932 | 5.67 | 679,901.10 | 11.39 | 12.70 | 12.61 | 14.11 | 64.34 | 63.15 | 29.84 | 33.96 | 3.43 | 51.04 | 0.1058 | 40.95 | -5.90 | 11.86 | -7.11 | 13.48 | 13.44 | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 339.03m | -25.96m | 5.88bn | 592.00 | -- | 1.98 | -- | 17.36 | -0.3096 | -0.3096 | 4.04 | 35.38 | 0.0903 | 1.85 | 6.13 | 572,683.70 | -0.6919 | 20.36 | -0.796 | 24.55 | 58.22 | 62.71 | -7.66 | 31.89 | 3.22 | -- | 0.1329 | 28.76 | -13.29 | 3.90 | 99.46 | -- | -9.88 | -- |
| Shenzhen Lifotronic Technology Co Ltd | 1.05bn | 251.02m | 5.93bn | 1.67k | 23.41 | 2.82 | -- | 5.62 | 0.5907 | 0.5907 | 2.47 | 4.90 | 0.3855 | 2.51 | 5.74 | 631,202.60 | 8.98 | 14.03 | 12.10 | 17.34 | 61.03 | 62.46 | 23.30 | 27.25 | 3.00 | -- | 0.1406 | 39.01 | 0.2024 | 22.12 | 5.12 | 27.99 | -1.63 | 18.64 |
| Cowealth Medical China Co Ltd | 777.03m | -11.37m | 6.74bn | 203.00 | -- | 6.10 | -- | 8.67 | -0.0285 | -0.0285 | 1.97 | 2.78 | 0.5206 | 3.32 | 1.00 | 3,827,724.00 | -0.7168 | 4.75 | -0.9393 | 6.35 | 16.38 | 20.19 | -1.38 | 5.56 | 2.65 | -- | 0.0229 | 33.36 | -14.05 | -2.15 | -41.58 | -16.31 | 2.73 | -- |
Data as of Feb 11 2026. Currency figures normalised to Shenzhen Lifotronic Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 8.71m | 2.05% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 2.46m | 0.58% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.04m | 0.48% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.95m | 0.46% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 1.12m | 0.26% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 696.93k | 0.16% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 684.17k | 0.16% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 641.14k | 0.15% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 454.41k | 0.11% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 273.60k | 0.06% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
